Monoamine metabolites in cerebrospinal fluid in multiple sclerosis

Area of Science:

• Neurochemistry
• Neurology
• Biomarkers

Background:

• Neurotransmitter metabolites in cerebrospinal fluid (CSF) are potential biomarkers for neurological diseases.
• Previous studies have yielded inconsistent results, possibly due to variations in lumbar puncture procedures.

Purpose of the Study:

• To investigate the concentrations of homovanillic acid (HVA), 5-hydroxyindoleacetic acid (5-HIAA), and 4-hydroxy, 3-methoxyphenylethylene glycol (MHPG) in CSF of multiple sclerosis (MS) patients.
• To assess the impact of standardized lumbar puncture procedures on HVA measurements.
• To explore correlations between metabolite levels and clinical parameters in MS.

Main Methods:

• CSF samples were collected from control subjects and patients with probable or definite multiple sclerosis (MS).
• Concentrations of HVA, 5-HIAA, and MHPG were measured using established analytical techniques.
• CSF was obtained under both standardized (fasting, recumbent) and non-standardized conditions in control subjects.

Main Results:

• Homovanillic acid (HVA) concentrations in controls were lower under standardized lumbar puncture conditions.
• Patients with multiple sclerosis (MS) exhibited significantly lower CSF 5-hydroxyindoleacetic acid (5-HIAA) levels compared to controls.
• CSF HVA concentrations did not differ between MS patients and controls.
• No significant correlations were found between metabolite levels and MS disease characteristics (lesion site, duration, gamma-globulin, recent relapse).

Conclusions:

• Standardized lumbar puncture is essential for reliable CSF metabolite analysis.
• Reduced CSF 5-HIAA may represent a potential neurochemical marker in multiple sclerosis (MS).
• HVA and MHPG levels do not appear to be significantly altered in MS based on this study.